Internal Medicine · Los Angeles, CA
NPI
1821171604
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1340 N Virgil Ave
Los Angeles, CA, 90027
Phone (323) 664-0013
Groups this clinician bills Medicare through
Medicare paid, 2024
$306K
5,589 services
Medicare patients, 2024
246
Average age 79
Drug cost, 2024
$3.5M
24,082 prescriptions
Company payments, 2025
$495
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hagop Bezikian was code 99213 (office e&m - established), 1,569 times for 227 patients. In total Hagop Bezikian billed 5,589 services in 34 codes, and Medicare paid $306K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,569 | 227 | $68.53 | $108K |
| 76882 Ultrasound - Nonspecific | Office | 742 | 161 | $52.25 | $39K |
| 20610 Joint Injection | Office | 626 | 144 | $50.55 | $32K |
| 82947 Clinical Chemistry | Office | 561 | 100 | $3.85 | $2,160 |
| 76942 Ultrasound - Nonspecific | Office | 526 | 135 | $49.89 | $26K |
| 99232 Hospital E&M - Subsequent | Facility | 215 | 31 | $63.81 | $14K |
| 36415 Venipuncture Blood Collection | Office | 204 | 140 | $8.65 | $1,765 |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 187 | 42 | $52.15 | $9,752 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 148 | 73 | $46.59 | $6,896 |
| 64450 Musculoskeletal | Office | 123 | 29 | $61.13 | $7,519 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 119 | 76 | $87.05 | $10K |
| 93306 Echocardiography (TTE/TEE) | Office | 51 | 51 | $172.78 | $8,812 |
| 99212 Office E&M - Established | Office | 48 | 37 | $42.38 | $2,034 |
| 99222 Hospital E&M - Initial | Facility | 42 | 28 | $100.88 | $4,237 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 35 | 35 | $100.51 | $3,518 |
By year: 2022 $320K for 6,058 services; 2023 $272K for 5,118 services; 2024 $306K for 5,589 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 561 | 100 | $3.85 | $2,160 |
| 36415 Venipuncture Blood Collection | 204 | 140 | $8.65 | $1,765 |
Medicare prescription drug claims, 2024
In 2024, the drug Hagop Bezikian prescribed most often to Medicare patients was Rosuvastatin Calcium, with 853 prescriptions and refills. In total Hagop Bezikian wrote 24,082 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 853 | 907 | 92 | $2,765 |
| Clonidine Hcl Generic | 636 | 645 | 68 | $933 |
| Ibuprofen Generic | 594 | 600 | 61 | $3,429 |
| Metoprolol Succinate Generic | 532 | 589 | 63 | $2,386 |
| Amlodipine Besylate Generic | 510 | 536 | 56 | $600 |
| Losartan Potassium Generic | 488 | 502 | 58 | $1,123 |
| Gabapentin Generic | 475 | 479 | 46 | $1,500 |
| Vascepa Icosapent Ethyl | 436 | 445 | 55 | $111K |
| Linzess Linaclotide | 423 | 428 | 55 | $220K |
| Omeprazole Generic | 409 | 411 | 45 | $690 |
| Tamsulosin Hcl Generic | 376 | 394 | 44 | $1,746 |
| Dexlansoprazole Dr Dexlansoprazole | 357 | 375 | 48 | $62K |
| Meclizine Hcl Generic | 344 | 346 | 41 | $1,945 |
| Levothyroxine Sodium Generic | 332 | 336 | 29 | $1,100 |
| Ropinirole Hcl Generic | 326 | 328 | 31 | $721 |
Brand drugs: 4,424 claims; generic drugs: 19,325 claims; opioid claims: 392.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hagop Bezikian $495 ($495 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $461.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.